Reaction
Rheumatoid Factor Increased reporting signals
As of the last recalculation, Rheumatoid Factor Increased appears in 1,104 FAERS reports alongside 22 co-occurring drug terms. The strongest observed disproportionality signal is METHYLPREDNISOLONE ACETATE (PRR 55.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Methylprednisolone Acetate | 23 | 55.3 | 55.4 |
| Diphenhydramine Hydrochloride Capsule, Liquid Filled | 48 | 44.2 | 44.3 |
| Esomeprazole Magnesium Capsule, Delayed Release | 32 | 42.8 | 42.9 |
| Esomeprazole Magnesium Delayed Release Capsules | 32 | 42.8 | 42.9 |
| Esomeprazole Magnesium Dihydrate | 32 | 42.6 | 42.7 |
| Cetirizine Hydrochloride Allergy | 47 | 30.5 | 30.6 |
| Cetirizine Hydrochloride Tablets | 47 | 30.5 | 30.6 |
| Vitamin E | 41 | 25.5 | 25.5 |
| Tofacitinib Citrate | 14 | 20.4 | 20.4 |
| Leflunomide | 99 | 19.5 | 19.5 |
| Duloxetine | 61 | 17.4 | 17.4 |
| Tapentadol Hydrochloride | 26 | 15.0 | 15.0 |
| Loperamide Hydrochloride Oral | 8 | 14.9 | 14.9 |
| Tocilizumab | 79 | 14.0 | 14.0 |
| Cetirizine | 53 | 13.5 | 13.5 |
| Etanercept | 287 | 11.9 | 11.9 |
| Loperamide Hcl | 8 | 11.8 | 11.8 |
| Tofacitinib | 104 | 11.6 | 11.6 |
| Dolutegravir Sodium | 5 | 10.5 | 10.5 |
| Abatacept | 69 | 10.0 | 10.0 |
| Golimumab | 32 | 7.2 | 7.2 |
| Glecaprevir And Pibrentasvir | 3 | 5.2 | 5.2 |